The harms of benzodiazepines for patients with dementia.

CMAJ

Women's College Research Institute (Rochon), Women's College Hospital; Department of Medicine (Rochon, Vozoris), Institute of Health Policy, Management, and Evaluation (Rochon), University of Toronto; Department of Medicine and Keenan Research Centre in the Li Ka Shing Knowledge Institute (Vozoris), St. Michael's Hospital, Toronto, Ont.; Department of Medicine (Gill), Queen's University; Institute for Clinical Evaluative Sciences (Gill), Kingston, Ont.

Published: April 2017

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386844PMC
http://dx.doi.org/10.1503/cmaj.170193DOI Listing

Publication Analysis

Top Keywords

harms benzodiazepines
4
benzodiazepines patients
4
patients dementia
4
harms
1
patients
1
dementia
1

Similar Publications

Background: The substance use crisis continues to progress. Medication for Opioid Use Disorder (MOUD) are prescribed to reduce opioid use and related harms; however, many individuals continue to use substances while on treatment. The objective of this study was to describe the temporal and demographic trends of the agreement between self-reported and urine tested substances.

View Article and Find Full Text PDF

Sexual problems relevant to psychotherapy, such as compulsive sexual behavior (CSB) and sexual functioning problems (SFP), have been related to harmful substance use in several studies. Substance use is prevalent among medical students (MS) and is often considered a maladaptive coping strategy for stress, as well as a risk factor for mental health issues. Sexual problems and substance use share trauma exposure and post-traumatic symptoms as risk factors for their development.

View Article and Find Full Text PDF

Introduction: In Canada, the COVID-19 pandemic collided with an ongoing overdose crisis driven by a toxic unregulated drug supply. Public health guidance intended to limit transmission of COVID-19 (e.g.

View Article and Find Full Text PDF

Introduction: Opioids and benzodiazepines are commonly prescribed for cancer symptoms. In combination, they can increase the risk of adverse events, particularly for older adults with multimorbidity, who represent most patients with cancer. We aimed to understand cancer care providers' practices for opioid and benzodiazepine coprescribing and mitigating potential harms.

View Article and Find Full Text PDF
Article Synopsis
  • * A scoping review examined driving performance assessments related to BZRA use, analyzing 183 studies that featured various drugs, with zopiclone being the most researched.
  • * Results showed that a significant number of studies found impairment in driving performance, with an emphasis on using certain measures like the Standard Deviation of Lateral Position (SDLP) in experimental settings, and biological detection methods in observational studies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!